Estimates Revisions Silexion Therapeutics Corp
Stocks
SLXN
KYG1281K1489
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
2026-08-27
|
5-day change | 1st Jan Change | ||
| 0.3602 USD | +1.49% |
|
-9.72% | -98.12% |
| 08-14 | Silexion Therapeutics Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-12 | Top Premarket Decliners | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- SLXN Stock
- Consensus Silexion Therapeutics Corp
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
